American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
NO
Nordicus Partners Corp
$4.07
+0.25%
OTC: NORD · 15-min delayed
$5.0KRevenue · FY2025
-$2.9MNet income
NORDOTC
About Nordicus Partners Corp
NORDICUS PARTNERS CORP
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2025
- $5.0K
- Net income
- -$2.9M
- Total assets
- $70.2M
Source: SEC EDGAR · updated Jun 7, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Reported a net loss of $2.9M in FY2025.
- Trading 29% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Nordicus Partners Corp.
Write a review
Newsroom
News about Nordicus Partners Corp
Orocidin and Syngene Partner to Accelerate Biotech Innovation
Nordicus Partners Corporation Announces Key Milestone in Development of Orocidin’s Breakthrough Treatment for Periodontitis
Nordicus Partners Corporation Enters Into A Consultancy Agreement With BIO-CONVERT In Denmark
Orocidin – New Insights Into The Treatment Of Periodontitis
Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
Nordicus Partners Corporation Engages FORCE Family Office
News & sentiment via Polygon.io
Explore
Browse all →
